Review article · 2024 · Open access
Drug repurposing for cancer therapy
Signal Transduction and Targeted Therapy, 9(1), 92 · Published 18 April 2024 · DOI 10.1038/s41392-024-01808-1
In brief
“Drug repurposing for cancer therapy” is a 2024 review article by Ying Xia and 3 co-authors, published in Signal Transduction and Targeted Therapy. OpenAlex counts 516 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Signal Transduction and Targeted Therapy.
- Citations
- 516
- Most cited in
- 2025 (238)
- Field-weighted impact
- 13.28
- References
- 507
- Authors
- 4
Abstract
Cancer, a complex and multifactorial disease, presents a significant challenge to global health. Despite significant advances in surgical, radiotherapeutic and immunological approaches, which have improved cancer treatment outcomes, drug therapy continues to serve as a key therapeutic strategy. However, the clinical efficacy of drug therapy is often constrained by drug resistance and severe toxic side effects, and thus there remains a critical need to develop novel cancer therapeutics. One promising strategy that has received widespread attention in recent years is drug repurposing: the identification of new applications for existing, clinically approved drugs. Drug repurposing possesses several inherent advantages in the context of cancer treatment since repurposed drugs are typically cost-effective, proven to be safe, and can significantly expedite the drug development process due to their already established safety profiles. In light of this, the present review offers a comprehensive overview of the various methods employed in drug repurposing, specifically focusing on the repurposing of drugs to treat cancer. We describe the antitumor properties of candidate drugs, and discuss in detail how they target both the hallmarks of cancer in tumor cells and the surrounding tumor microenvironment. In addition, we examine the innovative strategy of integrating drug repurposing with nanotechnology to enhance topical drug delivery. We also emphasize the critical role that repurposed drugs can play when used as part of a combination therapy regimen. To conclude, we outline the challenges associated with repurposing drugs and consider the future prospects of these repurposed drugs transitioning into clinical application.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Xia, Y., Sun, M. H., Huang, H., & Jin, W. (2024). Drug repurposing for cancer therapy. Signal Transduction and Targeted Therapy, 9(1), 92. https://doi.org/10.1038/s41392-024-01808-1
MLA 9
Xia, Ying, et al. “Drug repurposing for cancer therapy.” Signal Transduction and Targeted Therapy, vol. 9, no. 1, 2024, p. 92. https://doi.org/10.1038/s41392-024-01808-1.
Chicago
Xia, Ying, Ming Hua Sun, Hai Huang, and Weilin Jin. 2024. “Drug repurposing for cancer therapy.” Signal Transduction and Targeted Therapy 9 (1): 92. https://doi.org/10.1038/s41392-024-01808-1.
Harvard
Xia, Y. et al. (2024) ‘Drug repurposing for cancer therapy’, Signal Transduction and Targeted Therapy, 9(1), p. 92. doi:10.1038/s41392-024-01808-1.
IEEE
Y. Xia, M. H. Sun, H. Huang, and W. Jin, “Drug repurposing for cancer therapy,” Signal Transduction and Targeted Therapy, vol. 9, no. 1, p. 92, 2024, doi: 10.1038/s41392-024-01808-1.
BibTeX
@article{xia2024drug,
title = {{Drug repurposing for cancer therapy}},
author = {Xia, Ying and Sun, Ming Hua and Huang, Hai and Jin, Weilin},
journal = {Signal Transduction and Targeted Therapy},
year = {2024},
volume = {9},
number = {1},
pages = {92},
doi = {10.1038/s41392-024-01808-1},
url = {https://doi.org/10.1038/s41392-024-01808-1}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 1 | |
| 2024 | 62 | |
| 2025 | 238 | |
| 2026 | 215 |
Its field-weighted citation impact is 13.28: it has been cited 13.28 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- drug repurposing
- cancer therapy
- cancer hallmarks
- tumor microenvironment
- drug resistance
- combination therapy
- nanotechnology
- topical drug delivery
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Xia, Y., Sun, M. H., Huang, H., & Jin, W. (2024). Drug repurposing for cancer therapy. Signal Transduction and Targeted Therapy, 9(1), 92. https://doi.org/10.1038/s41392-024-01808-1
How many times has this paper been cited?
516 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Signal Transduction and Targeted Therapy.
Who wrote this paper?
Ying Xia, Ming Hua Sun, Hai Huang, Weilin Jin.
What is the DOI of this paper?
10.1038/s41392-024-01808-1. The permanent link is https://doi.org/10.1038/s41392-024-01808-1.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.